Immunovant (IMVT) Q2 2025 Earnings

29MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.76
-0.68
-0.6
-0.52

Details

Expected EPS
-0.713265
Actual EPS
-0.64
Surprise EPS
0.07
Surprise Percent
+10.27%

Description

Immunovant (IMVT) has reported earnings of -0.64 per share for Q2 2025.

0 Comments

Share your thoughts